Skip to main content
. 2022 May 23;28(7):1377–1380. doi: 10.1038/s41591-022-01874-4

Fig. 1. Study participants and cohort eligibility, 6 December 2021 through 26 February 2022.

Fig. 1

Participants were 3–5 years of age, affiliated to the FONASA, the public national healthcare system, and received two doses of CoronaVac, 28 days apart between 6 December 2021 and 26 February 2022 or did not receive any COVID-19 vaccination. We excluded children who had probable or confirmed COVID-19 according to RT–PCR assay for SARS-CoV-2 or antigen test before 6 December 2021.